Involvement of the Gab2 scaffolding adapter in type I interferon signalling

被引:12
|
作者
Baychelier, Florence
Nardeux, Pierre-Claude
Cajean-Feroldi, Chantal
Ermonval, Myriam
Guymarho, Jacqueline
Tovey, Michaeel G.
Eid, Pierre
机构
[1] CNRS, FRE 2937, Lab Oncol Virale, F-94801 Villejuif, France
[2] CNRS, FRE 2937, Lab Differenciat Cellulaire & Prions, F-94801 Villejuif, France
关键词
interferon-receptor; gab2-mutagenesis; phosphorylation; proteomics;
D O I
10.1016/j.cellsig.2007.05.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interferons (IFNs) are pleiotropic cytokines involved in the regulation of physiological and pathological processes. Upon interaction with their specific receptors, IFNs activate the Jak/STAT signalling pathway. Numerous studies suggest, however, that the classical Jak/STAT pathway cannot alone account for the wide range of IFN's biological effects. To better understand the role of alternative signalling pathways in the type I IFNs response, we analyzed novel tyrosine-phosphorylated proteins following IFN-alpha 2 stimulation. We showed for the first time that the Grb2-associated binder 2 (Gab2) protein is differentially phosphorylated upon the IFN subtype employed and the cells stimulated. We demonstrated that IFNAR1 physically interacts with Gab2. Moreover, the cellular content of Gab2 varies as a function of IFN receptor chain expression levels, and in particular of the ratio of IFNAR1 to IFNAR2, suggesting that Gab2 and IFNAR2 compete for interaction with IFNAR1. Analysis of Gab2 deletion mutants indicates that IFNAR1 might interact with a Gab2 region containing p85-P13'kinase binding sites. Our results shed new light on recent data involving both Gab2 and type I IFNs in osteoclastogenesis and oncogenesis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:2080 / 2087
页数:8
相关论文
共 50 条
  • [21] The role of Grb2 associated binder 2 (Gab2) scaffolding adaptor protein in B cell receptor signaling
    Maus, M
    Kövesdi, D
    Medgyesi, D
    Sarmay, G
    FEBS JOURNAL, 2005, 272 : 322 - 323
  • [22] The scaffolding adaptor GAB2 promotes anchorage independence and drives a transcriptional program associated to metastatic progression of breast cancer
    Medico, E.
    Isella, C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 205 - 205
  • [23] A scaffolding protein Gab2 is involved in postnatal development and lipopolysaccharide-induced activation of brain microglia of the mice.
    Park, H-S.
    Byeon, J. W.
    Kim, J. H.
    Kim, H. R.
    Go, H.
    Park, H. T.
    GLIA, 2019, 67 : E633 - E633
  • [24] Type I-interferon signalling in fish
    Collet, B
    Secombes, CJ
    FISH & SHELLFISH IMMUNOLOGY, 2002, 12 (05) : 389 - 397
  • [25] A novel GAB2::BRAF fusion in cutaneous non-Langerhans-cell histiocytosis with systemic involvement
    Wu, Bicong
    Konnick, Eric Q.
    Kimble, Erik L.
    Hendrie, Paul C.
    Shinohara, Michi M.
    Moshiri, Ata S.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2022, 49 (08) : 727 - 730
  • [26] Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein
    Brummer, Tilman
    Larance, Mark
    Abreu, Maria Teresa Herrera
    Lyons, Ruth J.
    Timpson, Paul
    Emmerich, Christoph H.
    Fleuren, Emmy D. G.
    Lehrbach, Gillian M.
    Schramek, Daniel
    Guilhaus, Michael
    James, David E.
    Daly, Roger J.
    EMBO JOURNAL, 2008, 27 (17): : 2305 - 2316
  • [27] Identification of tyrosine residues of importance for survival signaling through the scaffolding protein Gab2 in both wild-type FLT3 and the FLT3-ITD
    Masson, Kristina
    Liu, Tao
    Sun, Jianmin
    Ronnstrand, Lars
    BLOOD, 2007, 110 (11) : 484A - 484A
  • [28] Screening of Natural Compounds Affecting Type I Interferon Signalling
    Bollati-Fogolin, M.
    Oggero, M.
    Mirazo, S.
    Frank, R.
    Kratje, R.
    Muller, W.
    CELLS AND CULTURE, 2010, 4 : 485 - 487
  • [29] Signalling pathways mediating type I interferon gene expression
    Edwards, Michael R.
    Slater, Louise
    Johnston, Sebastian L.
    MICROBES AND INFECTION, 2007, 9 (11) : 1245 - 1251
  • [30] CNS disease associated with enhanced type I interferon signalling
    Crow, Y. J.
    LANCET NEUROLOGY, 2024, 23 (11): : 1158 - 1168